Malignant is punchy and persuasive, and the author is clearly in command of his subject matter. Prasad offers valuable advice on how to keep up with research as well as the appropriate way to analyse clinical trial reports.

-- Talha K Burki ? The Lancet Hematology

Aimed at general readers (including patients), oncology trainees and experts in health-care policy, it informs and disturbs throughout.

-- Andrew Robinson ? Nature

Patients should ask their oncologist how good the cure is: do I really live longer and better than doing "nothing"? Let them start by asking whether their doctor has read Prasad's book.

? Zurich Weekly News Review

[Malignant is] so applicable to the issues of the pandemic . . . Because what we're seeing is a research infrastructure that is not set up to do rapid evaluation, and to be resilient and to respond to a health crisis.

-- Marty Makary, MD, MPH ? MedPage Today Vinayak K. Prasad, MD, MPH is a practicing hematologist-oncologist and internal medicine physician. An associate professor of medicine and public health at Oregon Health & Science University, he is the coauthor of Ending Medical Reversal: Improving Outcomes, Saving Lives.